Page last updated: 2024-08-21

benzoxazoles and Melanoma

benzoxazoles has been researched along with Melanoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Kiełbik, A; Kulbacka, J; Novickij, V; Rembiałkowska, N; Saczko, J; Szewczyk, A; Szlasa, W; Tarek, M	1
Arnér, ES; Brodin, B; Campbell, J; Drummond, CJ; Higgins, M; Laín, S; McCarthy, AR; Sachweh, MC; Stafford, WC	1

Other Studies

2 other study(ies) available for benzoxazoles and Melanoma

Article	Year
Oxidative Effects during Irreversible Electroporation of Melanoma Cells-In Vitro Study. Molecules (Basel, Switzerland), 2020, Dec-31, Volume: 26, Issue:1 Topics: Benzoxazoles; Cell Membrane; Cell Membrane Permeability; Electroporation; Humans; In Vitro Techniques; Lipids; Melanoma; Oxidative Stress; Quinolinium Compounds; Skin Neoplasms; Tumor Cells, Cultured	2020
Redox effects and cytotoxic profiles of MJ25 and auranofin towards malignant melanoma cells. Oncotarget, 2015, Jun-30, Volume: 6, Issue:18 Topics: Animals; Antineoplastic Agents; Auranofin; Benzothiazoles; Benzoxazoles; Cell Line, Tumor; Cell Survival; Enzyme Activation; Glutathione; Glutathione Reductase; HCT116 Cells; Humans; Imidazoles; Indoles; Melanoma; Mice; Oxidation-Reduction; Oxidative Stress; Piperazines; Reactive Oxygen Species; Sulfonamides; Sulfones; Thioredoxin Reductase 1; Tumor Suppressor Protein p53; Vemurafenib	2015

Article

Year

Oxidative Effects during Irreversible Electroporation of Melanoma Cells-In Vitro Study.

Molecules (Basel, Switzerland), 2020, Dec-31, Volume: 26, Issue:1

Topics: Benzoxazoles; Cell Membrane; Cell Membrane Permeability; Electroporation; Humans; In Vitro Techniques; Lipids; Melanoma; Oxidative Stress; Quinolinium Compounds; Skin Neoplasms; Tumor Cells, Cultured

2020

Redox effects and cytotoxic profiles of MJ25 and auranofin towards malignant melanoma cells.

Oncotarget, 2015, Jun-30, Volume: 6, Issue:18

Topics: Animals; Antineoplastic Agents; Auranofin; Benzothiazoles; Benzoxazoles; Cell Line, Tumor; Cell Survival; Enzyme Activation; Glutathione; Glutathione Reductase; HCT116 Cells; Humans; Imidazoles; Indoles; Melanoma; Mice; Oxidation-Reduction; Oxidative Stress; Piperazines; Reactive Oxygen Species; Sulfonamides; Sulfones; Thioredoxin Reductase 1; Tumor Suppressor Protein p53; Vemurafenib

2015